Paladino N, Fainboim H, Theiler G, Schroder T, Munoz AE, Flores AC, et al. Gender susceptibility to chronic hepatitis C virus infection associated with interleukin 10 promoter polymorphism. Journal of virology. 2006;80(18):9144-50.
Akkaya O, Kiyici M, Yilmaz Y, Ulukaya E, Yerci O. Clinical significance of activity of ALT enzyme in patients with hepatitis C virus. World journal of gastroenterology : WJG. 2007;13(41):5481-5.
Suruki RY, Mueller N, Hayashi K, Harn D, DeGruttola V, Raker CA, et al. Host immune status and incidence of hepatocellular carcinoma among subjects infected with hepatitis C virus: a nested case-control study in Japan. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 2006;15(12):2521-5.
Quiroga JA, Martin J, Pardo M, Carreno V. Serum levels of soluble immune factors and pathogenesis of chronic hepatitis C, and their relation to therapeutic response to interferon-alpha. Digestive diseases and sciences. 1994;39(11):2485-96.
Sariban E, Imamura K, Luebbers R, Kufe D. Transcriptional and posttranscriptional regulation of tumor necrosis factor gene expression in human monocytes. The Journal of clinical investigation. 1988;81(5):1506-10.
Zekri AR, Hafez MM, Bahnassy AA, Hassan ZK, Mansour T, Kamal MM, et al. Genetic profile of Egyptian hepatocellular-carcinoma associated with hepatitis C virus Genotype 4 by 15 K cDNA microarray: preliminary study. BMC research notes. 2008;1:106.
Smith CA, Farrah T, Goodwin RG. The TNF receptor superfamily of cellular and viral proteins: activation, costimulation, and death. Cell. 1994;76(6):959-62.
Martinez A, Fernandez-Arquero M, Pascual-Salcedo D, Conejero L, Alves H, Balsa A, et al. Primary association of tumor necrosis factor-region genetic markers with susceptibility to rheumatoid arthritis. Arthritis and rheumatism. 2000;43(6):1366-70.
Fukuda R, Ishimura N, Ishihara S, Chowdhury A, Morlyama N, Nogami C, et al. Intrahepatic expression of pro-inflammatory cytokine mRNAs and interferon efficacy in chronic hepatitis C. Liver. 1996;16(6):390-9.
Nelson DR, Lim HL, Marousis CG, Fang JW, Davis GL, Shen L, et al. Activation of tumor necrosis factor-alpha system in chronic hepatitis C virus infection. Digestive diseases and sciences. 1997;42(12):2487-94.
Dai CY, Chuang WL, Chang WY, Chen SC, Lee LP, Hsieh MY, et al. Tumor necrosis factor- alpha promoter polymorphism at position -308 predicts response to combination therapy in hepatitis C virus infection. The Journal of infectious diseases. 2006;193(1):98-101.
Kusumoto K, Uto H, Hayashi K, Takahama Y, Nakao H, Suruki R, et al. Interleukin-10 or tumor necrosis factor-alpha polymorphisms and the natural course of hepatitis C virus infection in a hyperendemic area of Japan. Cytokine. 2006;34(1-2):24-31.
Rosen HR, McHutchison JG, Conrad AJ, Lentz JJ, Marousek G, Rose SL, et al. Tumor necrosis factor genetic polymorphisms and response to antiviral therapy in patients with chronic hepatitis C. The American journal of gastroenterology. 2002;97(3):714-20.
Tambur AR, Ortegel JW, Ben-Ari Z, Shabtai E, Klein T, Michowiz R, et al. Role of cytokine gene polymorphism in hepatitis C recurrence and allograft rejection among liver transplant recipients. Transplantation. 2001;71(10):1475-80.
Vidigal PG, Germer JJ, Zein NN. Polymorphisms in the interleukin-10, tumor necrosis factor-alpha, and transforming growth factor-beta1 genes in chronic hepatitis C patients treated with interferon and ribavirin. Journal of hepatology. 2002;36(2):271-7.
Yee LJ, Tang J, Gibson AW, Kimberly R, Van Leeuwen DJ, Kaslow RA. Interleukin 10 polymorphisms as predictors of sustained response in antiviral therapy for chronic hepatitis C infection. Hepatology (Baltimore, Md). 2001;33(3):708-12.
Yee LJ, Tang J, Herrera J, Kaslow RA, van Leeuwen DJ. Tumor necrosis factor gene polymorphisms in patients with cirrhosis from chronic hepatitis C virus infection. Genes and immunity. 2000;1(6):386-90.
Chen TY, Hsieh YS, Wu TT, Yang SF, Wu CJ, Tsay GJ, et al. Impact of serum levels and gene polymorphism of cytokines on chronic hepatitis C infection. Translational research : the journal of laboratory and clinical medicine. 2007;150(2):116-21.
Jeng JE, Tsai JF, Chuang LY, Ho MS, Lin ZY, Hsieh MY, et al. Tumor necrosis factor-alpha 308.2 polymorphism is associated with advanced hepatic fibrosis and higher risk for hepatocellular carcinoma. Neoplasia (New York, NY). 2007;9(11):987-92.
Valenti L, Pulixi E, Fracanzani AL, Dongiovanni P, Maggioni M, Orsatti A, et al. TNFalpha genotype affects TNFalpha release, insulin sensitivity and the severity of liver disease in HCV chronic hepatitis. Journal of hepatology. 2005;43(6):944-50.
Chew CS, Cherry CL, Imran D, Yunihastuti E, Kamarulzaman A, Varna S, et al. Tumour necrosis factor haplotypes associated with sensory neuropathy in Asian and Caucasian human immunodeficiency virus patients. Tissue antigens. 2011;77(2):126-30.
Puthothu B, Bierbaum S, Kopp MV, Forster J, Heinze J, Weckmann M, et al. Association of TNF-alpha with severe respiratory syncytial virus infection and bronchial asthma. Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology. 2009;20(2):157-63.
Basu M, Das T, Ghosh A, Majumder S, Maji AK, Kanjilal SD, et al. Gene-gene interaction and functional impact of polymorphisms on innate immune genes in controlling Plasmodium falciparum blood infection level. PloS one. 2012;7(10):e46441.
Messer G, Spengler U, Jung MC, Honold G, Blomer K, Pape GR, et al. Polymorphic structure of the tumor necrosis factor (TNF) locus: an NcoI polymorphism in the first intron of the human TNF-beta gene correlates with a variant amino acid in position 26 and a reduced level of TNF-beta production. The Journal of experimental medicine. 1991;173(1):209-19.
Elsammak MY, Al-Sharkaweey RM, Ragab MS, Amin GM, Kandil MH. In Egyptians, a mutation in the lymphotoxin-alpha gene may increase susceptibility to hepatitis C virus but not that to schistosomal infection. Annals of tropical medicine and parasitology. 2008;102(8):709-16.
Goyal A, Kazim SN, Sakhuja P, Malhotra V, Arora N, Sarin SK. Association of TNF-beta polymorphism with disease severity among patients infected with hepatitis C virus. Journal of medical virology. 2004;72(1):60-5.
Salehi Moghadam F, Mohebbi SR, Hosseini SM, Damavand B, Zali MR. A new subtype of hepatitis C virus genotype 3: analysis of available evidence. Hepatitis monthly. 2013;13(8):e13380.
Grunhage F, Nattermann J. Viral hepatitis: human genes that limit infection. Best practice & research Clinical gastroenterology. 2010;24(5):709-23.
Azimzadeh P RS, Mohebbi SR, Mahmoudi T, Vahedi M, Fatemi SR, Zali N, Zali MR. Association of polymorphisms in microRNA-binding sites and colorectal cancer in an Iranian population. Cancer Genet. 2012;205(10):501-7.
Behelgardi A HS, Mohebbi SR, Azimzadeh P, Derakhshani S, Karimi K. A Study on Genetic Association of Interleukin-16 Single Nucleotide Polymorphism (rs1131445) With Chronic Hepatitis B Virus Infection in Iranian Patients. Jundishapur J Microbiol. 2015;8(11):e23411.
Azimzadeh P RS, Mirtalebi H, Reza Fatemi S, Kazemian S, Khanyaghma M. Association of co-stimulatory human B-lymphocyte antigen B7-2 (CD86) gene polymorphism with colorectal cancer risk. Gastroenterology and Hepatology from Bed to Bench. 2013;6:68-91.
Najjar Sadeghi R SN, Vahedi M, Mohebbi SR, zali MR. Association of intron and exon polymorphisms of p53 gene in Iranian patients with gastritis. Gastroenterology and Hepatology from Bed to Bench. 2013;6(Suppl 1):S45-51.
Karkhane M MS, Azimzadeh P, Avarandeh H, Kazemian S, Sharifian A, Hatami B. Genetic association between a single nucleotide polymorphism in Interleukin-16 (rs4072111) and susceptibility to chronic HCV infection in an Iranian population. Gastroenterology and Hepatology from Bed to Bench. 2018;11(1):42-7.
Chen Y, Pei J. An assessment of a TNF polymorphic marker for the risk of HCV infection: meta-analysis and a new clinical study design. Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases. 2009;9(6):1356-63.
Makhatadze NJ. Tumor necrosis factor locus: genetic organisation and biological implications. Human immunology. 1998;59(9):571-9.
Bayley JP, Ottenhoff TH, Verweij CL. Is there a future for TNF promoter polymorphisms? Genes and immunity. 2004;5(5):315-29.
Fletcher GJ, Samuel P, Christdas J, Gnanamony M, Ismail AM, Anantharam R, et al. Association of HLA and TNF polymorphisms with the outcome of HBV infection in the South Indian population. Genes and immunity. 2011;12(7):552-8.
Gaudet MM, Egan KM, Lissowska J, Newcomb PA, Brinton LA, Titus-Ernstoff L, et al. Genetic variation in tumor necrosis factor and lymphotoxin-alpha (TNF-LTA) and breast cancer risk. Human genetics. 2007;121(3-4):483-90.
Vassalli P. The pathophysiology of tumor necrosis factors. Annual review of immunology. 1992;10:411-52.
Garcia-Gonzalez MA, Nicolas-Perez D, Lanas A, Bujanda L, Carrera P, Benito R, et al. Prognostic role of host cyclooxygenase and cytokine genotypes in a Caucasian cohort of patients with gastric adenocarcinoma. PloS one. 2012;7(9):e46179.
Aissani B, Ogwaro KM, Shrestha S, Tang J, Breen EC, Wong HL, et al. The major histocompatibility complex conserved extended haplotype 8.1 in AIDS-related non-Hodgkin lymphoma. Journal of acquired immune deficiency syndromes (1999). 2009;52(2):170-9.
BaradaranGhavami SH NS, Naghoosi H, Tahaei SME, Azimzadeh P, Damavand B, Romani S. Association between Lymphotoxin (LT-A) Gene Polymorphism and Susceptibility to Chronic Hepatitis C Infection in Iranian Patients. Journal of Kerman University of Medical Sciences. 2013;20(3):252-62.
BaradaranGhavami SH MS, Naghoosi H, Azimzadeh P, Tahaei E, Romani S, Almasi SH. Association of Tumor Necrosis Factor Alpha (TNF-α)-1031 Polymorphism with Chronic Infection of Patients with HCV. Journal of Babol University of Medical Sciences. 2012;14(5):70-6.